PTC THERAPEUTICS, INC. — Director's Dealing 2016

Apr 28, 2016

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: PTC THERAPEUTICS, INC. (PTCT)
CIK: 0001070081
Period of Report: 2016-04-22

Reporting Person: Ong Tuyen (Chief Medical Officer)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (right to buy)	$40.45	2024-09-22	Common Stock (75000)		Direct
Stock Option (right to buy)	$30.86	2026-01-03	Common Stock (37500)		Direct

Footnotes

F1: This option was granted on September 23, 2014 and vests over four years, with 25% of the shares underlying the option vested on September 8, 2015, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on December 8, 2015.

F2: This option was granted on January 4, 2016, and vests over four years, with 25% of the shares underlying the option vesting on January 4, 2017, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 4, 2017.